Abstract
Histologic sections from the specimens of 60 patients with urothelial carcinoma were stained immunohistochemically to search for beta-human chorionic gonadotropin (B-HCG) production. There were 6 doubtful, 5 weak and 1 strong positive B-HCG stainings among 65 sections from 60 patients. De novo acquisition of B-HCG production capability of tumour cells seemed to be predictive for early haematogenous dissemination of the disease, but the data obtained in this particular study were insufficient to suggest B-HCG as a routine prognostic marker.
Similar content being viewed by others
References
Soloway, M. S.: Evaluation and management of patients with superficial bladder cancer.Urol. Clin. North Am., 14, 771 (1987).
Yamase, H. T., Wurzel, R. S., Nieh, P. T., Gondos, B.: Immunohistochemical demonstration of human chorionic gonadotropin in tumours of the urinary bladder.Ann. Clin. Lab. Sci., 15, 414 (1985).
Shah, W. M., Newman, J., O'Brien, J. M., Considine, J.: Ectopic beta-human chorionic gonadotropin production by bladder urothelial neoplasia.Arch. Pathol. Lab. Med., 110 107 (1986).
Dexeus, F., Logothetis, C., Hossan, E., Samuels, M. L.: Carcinoembryonic antigen and beta-human chorionic gonadotropin as serum markers for advanced urothelial malignancies.J. Urol., 136, 403 (1986).
Johnson, D. E., Swanson, D. A., Eschenbach, A. C.: Tumours of the Genitourinary Tract. Appleton & Lange, USA (1988).
Javadpour, N.: Multiple cell markers in bladder cancer. Principles and clinical applications.Urol. Clin. North Am., 11, 609 (1984).
Coon, J. S., Weinstein, R. S., Summers, J. L.: Blood group precursor T-antigen expression in human bladder carcinoma.Am. J. Clin. Pathol., 77, 692 (1982).
Newman, A. J., Carlton, C. E., Johnson, S.: Cell surface A, B or O(H) blood group antigens as an indicator of malignant potential in stage A bladder carcinoma.J. Urol., 124, 27 (1980).
Abel, P. D., Thorpe, S. J., Williams, G.: Blood group antigen expression in frozen sections of presenting bladder cancer: 3-year prospective follow-up of prognostic value.Br. J. Urol., 63, 171 (1989).
Richie, J. P., Blute, R. D., Waisman, J.: Immunologic indicators of prognosis in bladder cancer: the importance of cell surface antigens.J. Urol., 123, 22 (1980).
Gustafson, H., Tribukait, B., Esposti, P. L.: DNA profile and tumour progression in patients with superficial bladder tumours.Urol. Res., 10, 13 (1982).
Summers, J. L., Coon, J. S., Ward, R. M.: Prognosis in carcinoma of the urinary bladder based upon tissue blood group ABH and Thomsen-Friedenreich antigen status and karyotype of the initial tumour.Cancer Res., 43, 934 (1983).
Carter, H. B., Amberson, J. B., Bander, N. H.: Newer diagnostic techniques for bladder cancer.Urol. Clin. North Am., 14, 763 (1987).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Özkardeş, H., Ergen, A., Özen, H.A. et al. Immunohistochemical detection of beta-human chorionic gonadotropin in urothelial carcinoma. International Urology and Nephrology 23, 5–11 (1991). https://doi.org/10.1007/BF02549722
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02549722